Home > Insider Trading > Filing (0001209191-16-146605)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1044378	Biocept Inc	BIOC	Pharmaceutical Preparations (2834)	CA

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024004	F David Hale	C/O Biocept, Inc. 5810 Nancy Ridge Drive #150 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2016-06-16	13,334	$0.00	18,190	No	5	G	Indirect	By LLC
Common Stock	Acquisiton	2016-06-16	13,334	$0.00	16,736	No	5	G	Indirect	By trust
Common Stock	Acquisiton	2016-10-19	90,909	$1.10	109,099	No	4	P	Indirect	By LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	5	G	Indirect	By LLC
No	5	G	Indirect	By trust
No	4	P	Indirect	By LLC

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant to Purchase Common Stock	Acquisiton	2016-10-19	90,909	$0.00	90,909	$1.10

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
90,909	2016-10-19	2021-10-19	No	4	P	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	42,718	Direct

Footnotes

As adjusted for the 1-for-3 reverse stock split effected September 27, 2016.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 36,380 fewer shares.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 33,468 fewer shares.
Shares were purchased from the issuer in a unit offering, with each unit consisting of one share of Common Stock and one warrant to purchase one share of Common Stock for $1.10 per unit.
On September 27, 2016, the Issuer effected a 1-for-3 reverse stock split resulting in the reporting person's ownership of 85,434 fewer shares.